2021 vaccines for adults

Ended Indefinite Delivery Contract Awarded Last action

Contract number
75D30121D11355
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$102,613,000.00
Maximum order
$50,713,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 6 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

Pfizer Inc. was awarded a multiple-award Indefinite Delivery Contract valued at $102.6 million by the Centers for Disease Control and Prevention (CDC) Pittsburgh on June 25, 2021, to supply 13 standard adult vaccines through June 30, 2022. The contract procures hepatitis A, hepatitis B, hepatitis A/B combination, pneumococcal polysaccharide, tetanus/diphtheria toxoids, herpes zoster, tetanus/diphtheria/acellular pertussis, measles/mumps/rubella, meningococcal conjugate, human papillomavirus, varicella, pneumococcal conjugate, and serogroup B meningococcal vaccines. All vaccines must be manufactured under current FDA licensure with a minimum 12-month shelf life and delivered within 15 business days of order receipt to destinations throughout the United States. This contract carries no small business set-aside designation and reflects Pfizer's established status as a large pharmaceutical manufacturer capable of meeting extensive government medical supply requirements.

The contract supports the CDC's Public Health Service Section 317(j) immunization program, which provides vaccines to up to 50 state health departments and large city immunization programs. The original solicitation, posted April 5, 2021, with a due date of April 20, 2021, sought indefinite-delivery, indefinite-quantity contract awards with estimated minimum order sizes specified for each vaccine type. The performance period spans July 1, 2021 through June 30, 2022, ensuring continuity of vaccine supply to support national public health immunization initiatives. This contract represents a critical component of the federal government's vaccine distribution infrastructure, enabling rapid procurement and delivery of adult vaccines to state and local health authorities nationwide.

Transactions

Action Obligated Date
Other Administrative Action P00011 -$2,181
Additional Work (new agreement, FAR part 6 applies) P00010 $0
Funding Only Action P00009 $3,142,026
Funding Only Action P00008 $1,000,113
Supplemental Agreement for work within scope P00007 $0
Funding Only Action P00006 $499,823
Funding Only Action P00005 $17,369
Additional Work (new agreement, FAR part 6 applies) P00004 $0
Funding Only Action P00003 $2,435,178
Other Administrative Action P00002 $0
Funding Only Action P00001 $266,227
Original award $1,055,627
Show all 12

Quick answers

Who was awarded contract 75D30121D11355?

75D30121D11355 was awarded to Pfizer Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on June 25, 2021.

How much is contract 75D30121D11355 worth?

75D30121D11355's own ceiling is $102,613,000. A single order can be worth up to $50,713,000.

Who can order from contract 75D30121D11355?

75D30121D11355 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75D30121D11355 competed?

The extent of competition for 75D30121D11355 was full and open competition. The government received 6 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login